EVGN · Evogene Ltd.
AI read · Bad for EVGN
The AI's read
The prior-year profit came mainly from income tied to the ICL transaction, so the profit-to-loss change does not tell the whole story. Sales still fell after the Bayer agreement ended. Research programs advanced, but the report gave no new results or sales from those efforts.